Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.
Addressing Disparities in Skin-Aging Prevention Among Women of Color
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Upadacitinib Outperforms Dupilumab in Primary and Secondary End Points in Head-to-Head AD Study
ReV Up Your Vitiligo Treatment Strategies
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers